| Authors: |
Solomon BJ; Peter MacCallum Cancer Centre, Melbourne, Australia., Tan DSW; National Cancer Centre Singapore, Duke-NUS Medical School, Singapore, Singapore., de Castro G Jr; Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil., Cobo M; Medical Oncology Intercenter Unit, Regional University Hospital and Virgen de la Victoria University Hospital, IBIMA, Málaga, Spain., Garassino MC; Department of Medicine, Section Hematology Oncology, Thoracic Oncology, University of Chicago, Chicago, Illinois., Zhang J; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas., Johnson BE; Dana-Farber Cancer Institute, Boston, Massachusetts., Lee JM; UCLA Health, Los Angeles, California., Garrido P; Hospital Universitario Ramón y Cajal, Madrid, Spain., Butler AA; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey., Pelletier MR; Novartis BioMedical Research, Cambridge, Massachusetts., Savchenko A; Precision Medicine, Novartis Pharmaceuticals Corporation, Cambridge, Massachusetts., Ji L; Novartis BioMedical Research, Cambridge, Massachusetts., Brase JC; Novartis Pharma AG, Basel, Switzerland., Caparica R; Novartis Pharma AG, Basel, Switzerland., Demanse D; Novartis Pharma AG, Basel, Switzerland., Wu J; Novartis BioMedical Research, Cambridge, Massachusetts., Bossen C; Novartis Pharma AG, Basel, Switzerland., Mok T; The Chinese University of Hong Kong, Hong Kong, China. |
